1
|
Cruz-Atienza VM, Tago J, Villafuerte C, Wei M, Garza-Girón R, Dominguez LA, Kostoglodov V, Nishimura T, Franco SI, Real J, Santoyo MA, Ito Y, Kazachkina E. Short-term interaction between silent and devastating earthquakes in Mexico. Nat Commun 2021; 12:2171. [PMID: 33846327 PMCID: PMC8042113 DOI: 10.1038/s41467-021-22326-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Accepted: 03/11/2021] [Indexed: 02/01/2023] Open
Abstract
Either the triggering of large earthquakes on a fault hosting aseismic slip or the triggering of slow slip events (SSE) by passing seismic waves involve seismological questions with important hazard implications. Just a few observations plausibly suggest that such interactions actually happen in nature. In this study we show that three recent devastating earthquakes in Mexico are likely related to SSEs, describing a cascade of events interacting with each other on a regional scale via quasi-static and/or dynamic perturbations across the states of Guerrero and Oaxaca. Such interaction seems to be conditioned by the transient memory of Earth materials subject to the "traumatic" stress produced by seismic waves of the great 2017 (Mw8.2) Tehuantepec earthquake, which strongly disturbed the SSE cycles over a 650 km long segment of the subduction plate interface. Our results imply that seismic hazard in large populated areas is a short-term evolving function of seismotectonic processes that are often observable.
Collapse
Affiliation(s)
- V. M. Cruz-Atienza
- grid.9486.30000 0001 2159 0001Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J. Tago
- grid.9486.30000 0001 2159 0001Facultad de Ingeniería, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - C. Villafuerte
- grid.9486.30000 0001 2159 0001Posgrado en Ciencias de la Tierra, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M. Wei
- grid.20431.340000 0004 0416 2242Graduate School of Oceanography, University of Rhode Island, Narragansett, USA
| | - R. Garza-Girón
- grid.205975.c0000 0001 0740 6917Department of Earth and Planetary Sciences, University of California, Santa Cruz, USA
| | - L. A. Dominguez
- grid.9486.30000 0001 2159 0001Escuela Nacional de Estudios Superiores, Universidad Nacional Autónoma de México, Morelia, Mexico
| | - V. Kostoglodov
- grid.9486.30000 0001 2159 0001Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - T. Nishimura
- grid.258799.80000 0004 0372 2033Disaster Prevention Research Institute, Kyoto University, Kyoto, Japan
| | - S. I. Franco
- grid.9486.30000 0001 2159 0001Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - J. Real
- grid.9486.30000 0001 2159 0001Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - M. A. Santoyo
- grid.9486.30000 0001 2159 0001Instituto de Geofísica, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - Y. Ito
- grid.258799.80000 0004 0372 2033Disaster Prevention Research Institute, Kyoto University, Kyoto, Japan
| | - E. Kazachkina
- grid.9486.30000 0001 2159 0001Posgrado en Ciencias de la Tierra, Universidad Nacional Autónoma de México, Mexico City, Mexico
| |
Collapse
|
2
|
Mata-Cases M, Mahon J, Mauricio D, Franch-Nadal J, Real J, Hex N. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs. BMC Health Serv Res 2020; 20:803. [PMID: 32847581 PMCID: PMC7448435 DOI: 10.1186/s12913-020-05360-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Accepted: 05/24/2020] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND To estimate the potential benefits in terms of avoided complications and cost reduction if the Spanish health system would encourage the intensification of treatment for better glycaemic control in adults with Type 2 diabetes from the current HbA1c target used in clinical practice of 68 mmol/mol to a target of 53 mmol/mol. METHODS The IQVIA Core Diabetes Model (version 9.0) was used to model the impact of these changes in respect of micro- and macrovascular complications and the associated costs. The modelling was based on data derived from the SIDIAP-Q population database from Catalonia, taking a random cohort of 10,000 people with type 2 diabetes and dividing it into sub-groups based on their baseline HbA1c. RESULTS The CDM modelling showed that the average cost reduction per person varies depending on baseline HbA1c. The model estimates that after 25 years, people with a baseline HbA1c between 48 and 58 mmol/mol and > 75 mmol/mol show an average cost reduction of €6027 and €11,966, respectively. Applying the per-person cost reduction to the cohorts of the prevalent population in Spain (1,910,374) the overall estimated cost reduction was €14.7 billion over 25 years. The improvements in outcomes resulted in an estimated reduction of more than 1.2 million complications cumulatively over 25 years, of which more than 550,000 relate to diabetic foot and more than 170,000 related to renal disease. CONCLUSION Over a 25 year period, Spain could considerably reduce costs and avoid major complications if, on a population level, more ambitious glycaemic control, according to Spanish or EU guidelines, could be achieved among people with type 2 diabetes by reducing the HbA1c threshold for treatment intensification. Although there is a slower trajectory for benefits in earlier years, there is a much more rapid benefit gain between years 5 and 15.
Collapse
Affiliation(s)
- M Mata-Cases
- DAP-Cat group, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Carrer Sardenya 375, entlo 1ª, 08025, Barcelona, Spain.
| | - J Mahon
- York Health Economics Consortium Ltd, University of York, York, UK
| | - D Mauricio
- DAP-Cat group, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Carrer Sardenya 375, entlo 1ª, 08025, Barcelona, Spain
| | - J Franch-Nadal
- DAP-Cat group, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Carrer Sardenya 375, entlo 1ª, 08025, Barcelona, Spain
| | - J Real
- DAP-Cat group, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Carrer Sardenya 375, entlo 1ª, 08025, Barcelona, Spain
| | - N Hex
- York Health Economics Consortium Ltd, University of York, York, UK
| |
Collapse
|
3
|
Cruz I, Serna C, Rué M, Real J, Galván L, Pifarré J. Comparative exposure to antipsychotic medications in immigrant and native-born populations of a Spanish health region. Eur Psychiatry 2020; 27:477-82. [DOI: 10.1016/j.eurpsy.2011.02.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2010] [Revised: 02/01/2011] [Accepted: 02/05/2011] [Indexed: 10/18/2022] Open
Abstract
AbstractBackgroundRaised rates of psychoses among ethnic minorities have been reported. Exposure to antipsychotic medications can give information on mental illness management and ethnic-related differences.ObjectiveTo compare exposure to antipsychotic medications in immigrant and native-born populations in Spain.MethodDescriptive cross-sectional study of the dispensation of antipsychotic medications to the population aged 15 to 64 years, in a Spanish Health Region during 2008.Results1.9% of the native-born population was exposed to antipsychotic medications as compared to 0.4% of the immigrant population. Native-born women were exposed from 1.8 to 5.3 times more and native-born men from 3.6 to 6.3 times more than immigrants of the same gender. The least exposed were persons from Eastern Europe and men from sub-Saharan Africa. Active ingredients prescribed were similar between the two groups. Of the immigrant group, 15.7% were admitted to a psychiatric ward as compared to 6.4% of the native-born population. In the former, non-specific diagnoses were predominant.ConclusionsAll immigrant groups had lower exposure to antipsychotic medications, were admitted to inpatient care more often and had less specific diagnoses. Both diagnostic processes and adherence to treatment need improvement in the regional immigrant population.
Collapse
|
4
|
Munoz M, Verdu J, Real J, Vinyoles E, Abellana R. P4384Epidemiology of heart failure in Spain. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M.A. Munoz
- Primary Care Research Institute (IDIAP), Barcelona, Spain
| | - J.M. Verdu
- Primary Care Research Institute (IDIAP), Barcelona, Spain
| | - J. Real
- Primary Care Research Institute (IDIAP), Barcelona, Spain
| | - E. Vinyoles
- Primary Care Research Institute (IDIAP), Barcelona, Spain
| | - R. Abellana
- Primary Care Research Institute (IDIAP), Barcelona, Spain
| | | |
Collapse
|
5
|
Karavana V, Smith I, Kanellis G, Sigala I, Kinsella T, Zakynthinos S, Liu L, Chen J, Zhang X, Liu A, Guo F, Liu S, Yang Y, Qiu H, Grimaldi DG, Kaya E, Acicbe O, Kayaalp I, Asar S, Dogan M, Eren G, Hergunsel O, Pavelescu D, Grintescu I, Mirea L, Guanziroli M, Gotti M, Marino A, Cressoni M, Vergani G, Chiurazzi C, Chiumello D, Gattinoni L, Guanziroli M, Gotti M, Vergani G, Cressoni M, Chiurazzi C, Marino A, Spano S, Chiumello D, Gattinoni L, Guanziroli M, Gotti M, Vergani G, Marino A, Cressoni M, Chiurazzi C, Chiumello D, Gattinoni L, Massaro F, Moustakas A, Johansson S, Larsson A, Perchiazzi G, Zhang XW, Guo FM, Chen JX, Xue M, Yang Y, Qiu HB, Chen JX, Liu L, Yang L, Zhang XW, Guo FM, Yang Y, Qiu HB, Fister M, Knafelj R, Suzer MA, Kavlak ME, Atalan HK, Gucyetmez B, Cakar N, Weller D, Grootendorst AF, Dijkstra A, Kuijper TM, Cleffken BI, Regli A, De Keulenaer B, Van Heerden P, Hadfield D, Hopkins PA, Penhaligon B, Reid F, Hart N, Rafferty GF, Grasselli G, Mauri T, Lazzeri M, Carlesso E, Cambiaghi B, Eronia N, Maffezzini E, Bronco A, Abbruzzese C, Rossi N, Foti G, Bellani G, Pesenti A, Bassi GL, Panigada M, Ranzani O, Kolobow T, Zanella A, Cressoni M, Berra L, Parrini V, Kandil H, Salati G, Livigni S, Livigni S, Amatu A, Girardis M, Barbagallo M, Moise G, Mercurio G, Costa A, Vezzani A, Lindau S, Babel J, Cavana M, Torres A, Panigada M, Bassi GL, Ranzani OT, Kolobow T, Zanella A, Cressoni M, Berra L, Parrini V, Kandil H, Salati G, Livigni S, Amatu A, Girardis M, Barbagallo M, Moise G, Mercurio G, Costa A, Vezzani A, Lindau S, Babel J, Cavana M, Torres A, Umbrello M, Taverna M, Formenti P, Mistraletti G, Vetrone F, Marino A, Vergani G, Baisi A, Chiumello D, Garnero AG, Novotni DN, Arnal JA, Urner M, Fan E, Dres M, Vorona S, Brochard L, Ferguson ND, Goligher EC, Leung C, Joynt G, Wong W, Lee A, Gomersall C, Poels S, Casaer M, Schetz M, Van den Berghe G, Meyfroidt G, Holzgraefe B, Von Kobyletzki LB, Larsson A, Cianchi G, Becherucci F, Batacchi S, Cozzolino M, Franchi F, Di Valvasone S, Ferraro MC, Peris A, Phiphitthanaban H, Wacharasint P, Wongsrichanalai V, Lertamornpong A, Pengpinij O, Wattanathum A, Oer-areemitr N, Boddi M, Cianchi G, Cappellini E, Ciapetti M, Batacchi S, Di Lascio G, Bonizzoli M, Cozzolino M, Peris A, Lazzeri C, Cianchi G, Bonizzoli M, Di Lascio G, Cozzolino M, Peris A, Katsin ML, Hurava MY, Dzyadzko AM, Hermann A, Schellongowski P, Bojic A, Riss K, Robak O, Lamm W, Sperr W, Staudinger T, Buoninsegni LT, Bonizzoli M, Cozzolino M, Parodo J, Ottaviano A, Cecci L, Corsi E, Ricca V, Peris A, de Garibay APR, Ende-Schneider B, Schreiber C, Kreymann B, Turani F, Resta M, Niro D, Castaldi P, Boscolo G, Gonsales G, Martini S, Belli A, Zamidei L, Falco M, Lamas T, Mendes J, Galazzi A, Mauri T, Benco B, Binda F, Masciopinto L, Lazzeri M, Carlesso E, Lissoni A, Grasselli G, Adamini I, Pesenti A, Thamjamrassri T, Watcharotayangul J, Numthavaj P, Kongsareepong S, Higuera J, Cabestrero D, Rey L, Narváez G, Blandino A, Aroca M, Saéz S, De Pablo R, Mohamed A, Sklar M, Munshi L, Mauri T, Lazzeri M, Alban L, Turrini C, Panigada M, Taccone P, Carlesso E, Marenghi C, Spadaro S, Grasselli G, Volta C, Pesenti A, Higuera J, Alonso DC, Blandino A, Narváez G, González LR, Aroca M, Saéz S, De Pablo R, Franci A, Stocchi G, Cappuccini G, Socci F, Cozzolino M, Guetti C, Rastrelli P, Peris A, Nestorowicz A, Glapinski J, Fijalkowska-Nestorowicz A, Wosko J, Fijalkowska-Nestorowicz A, Glapinski J, Wosko J, Duprez F, Bonus T, Cuvelier G, Mashayekhi S, Ollieuz S, Reychler G, Bonus T, Duprez F, Cuvelier G, Mashayekhi S, Ollieuz S, Reychler G, Kuchyn I, Bielka K, Sergienko A, Jones H, Day C, Park SC, Yeom SR, Myatra SN, Gupta S, Rajnala V, Divatia J, Silva JV, Olvera OA, Schulte RC, Bermudez MC, Zorrilla LP, Ferretis HL, García KT, Balciuniene N, Ramsaite J, Kriukelyte O, Krikscionaitiene A, Tamosuitis T, Terragni P, Brazzi L, Falco D, Pistidda L, Magni G, Bartoletti L, Mascia L, Filippini C, Ranieri V, Kyriakoudi A, Rovina N, Koltsida O, Konstantellou E, Kardara M, Kostakou E, Gavriilidis G, Vasileiadis I, Koulouris N, Koutsoukou A, Van Snippenburg W, Kröner A, Flim M, Buise M, Hemler R, Spronk P, Regli A, Noffsinger B, De Keulenaer B, Singh B, Hockings L, Van Heerden P, Spina C, Bronco A, Magni F, Di Giambattista C, Vargiolu A, Bellani G, Foti G, Citerio G, Scaramuzzo G, Spadaro S, Waldmann AD, Böhm SH, Ragazzi R, Volta CA, Heines SJ, Strauch U, Van de Poll MC, Roekaerts PM, Bergmans DC, Sosio S, Gatti S, Maffezzini E, Punzi V, Asta A, Foti G, Bellani G, Glapinski J, Mroczka J, Nestorowicz A, Fijalkowska-Nestorowicz A, Yaroshetskiy AI, Rezepov NA, Mandel IA, Gelfand BR, Ozen E, Karakoc E, Ayyildiz A, Kara S, Ekemen S, Yelken BB, Saasouh W, Freeman J, Turan A, Hajjej Z, Sellami W, Bousselmi M, Samoud W, Gharsallah H, Labbene I, Ferjani M, Vetrugno L, Barbariol F, Forfori F, Regeni I, Della Rocca G, Jansen D, Jonkman A, Doorduin J, Roesthuis L, Van der Hoeven J, Heunks L, Marocco SA, Bottiroli M, Pinciroli R, Galanti V, Calini A, Gagliardone M, Bellani G, Fumagalli R, Gatti S, Abbruzzese C, Ippolito D, Sala VL, Meroni V, Bronco A, Foti G, Bellani G, Elbanna M, Nassar Y, Abdelmohsen A, Yahia M, Mongodi S, Mojoli F, Via G, Tavazzi G, Fava F, Pozzi M, Iotti GA, Bouhemad B, Ruiz-Ferron F, Simón JS, Gordillo-Resina M, Chica-Saez V, Garcia MR, Vela-Colmenero R, Redondo-Orts M, Gontijo-Coutinho C, Ozahata T, Nocera P, Franci D, Santos T, Carvalho-Filho M, Fochi O, Gatti S, Nacoti M, Signori D, Bronco A, Bonacina D, Bellani G, Bonanomi E, Mongodi S, Bonvecchio E, Stella A, Roldi E, Orlando A, Luperto M, Bouhemad B, Iotti GA, Mojoli F, Trunfio D, Licitra G, Martinelli R, Vannini D, Giuliano G, Vetrugno L, Forfori F, Näslund E, Lindberg LG, Lund I, Larsson A, Frithiof R, Nichols A, Freeman J, Pentakota S, Kodali B, Pranskunas A, Kiudulaite I, Simkiene J, Damanskyte D, Pranskuniene Z, Arstikyte J, Vaitkaitis D, Pilvinis V, Brazaitis M, Pool R, Haugaa H, Botero A, Escobar D, Maberry D, Tønnessen T, Zuckerbraun B, Pinsky M, Gomez H, Lyons H, Trimmings A, Domizi R, Scorcella C, Damiani E, Pierantozzi S, Tondi S, Monaldi V, Carletti A, Zuccari S, Adrario E, Pelaia P, Donati A, Kazune S, Grabovskis A, Volceka K, Rubins U, Bol M, Suverein M, Delnoij T, Driessen R, Heines S, Delhaas T, Vd Poll M, Sels J, Jozwiak M, Chambaz M, Sentenac P, Richard C, Monnet X, Teboul JL, Bitar Z, Maadarani O, Al Hamdan R, Huber W, Malbrain M, Chew M, Mallat J, Tagami T, Hundeshagen S, Wolf S, Huber W, Mair S, Schmid R, Aron J, Adlam M, Dua G, Mu L, Chen L, Yoon J, Clermont G, Dubrawski A, Duhailib Z, Al Assas K, Shafquat A, Salahuddin N, Donaghy J, Morgan P, Valeanu L, Stefan M, Provenchere S, Longrois D, Shaw A, Mythen MG, Shook D, Hayashida D, Zhang X, Munson SH, Sawyer A, Mariyaselvam M, Blunt M, Young P, Nakwan N, Khwannimit B, Checharoen P, Berger D, Moller P, Bloechlinger S, Bloch A, Jakob S, Takala J, Van den Brule JM, Stolk R, Vinke E, Van Loon LM, Pickkers P, Van der Hoeven JG, Kox M, Hoedemaekers CW, Werner-Moller P, Jakob S, Takala J, Berger D, Bertini P, Guarracino F, Colosimo D, Gonnella S, Brizzi G, Mancino G, Baldassarri R, Pinsky MR, Bertini P, Gonnella S, Brizzi G, Mancino G, Amitrano D, Guarracino F, Goslar T, Stajer D, Radsel P, De Vos R, Dijk NBV, Stringari G, Cogo G, Devigili A, Graziadei MC, Bresadola E, Lubli P, Amella S, Marani F, Polati E, Gottin L, Colinas L, Hernández G, Vicho R, Serna M, Canabal A, Cuena R, Jozwiak M, Gimenez J, Teboul JL, Mercado P, Depret F, Richard C, Monnet X, Hajjej Z, Sellami W, Sassi K, Gharsallah H, Labbene I, Ferjani M, Herner A, Schmid R, Huber W, Abded N, Nassar Y, Elghonemi M, Monir A, Nikhilesh J, Apurv T, Uber AU, Grossestreuer A, Moskowitz A, Patel P, Holmberg MJ, Donnino MW, Graham CA, Hung K, Lo R, Leung LY, Lee KH, Yeung CY, Chan SY, Trembach N, Zabolotskikh I, Caldas J, Panerai R, Camara L, Ferreira G, Almeida J, de Oliveira GQ, Jardim J, Bor-Seng-Shu E, Lima M, Nogueira R, Jatene F, Zeferino S, Galas F, Robinson T, Hajjar LA, Caldas J, Panerai R, Ferreira G, Camara L, Zeferino S, Jardim J, Bor-Seng-Shu E, Oliveira M, Norgueira R, Groehs R, Ferreira-Santos L, Galas F, Oliveira G, Almeida J, Robinson T, Jatene F, Hajjar L, Ferreira G, Ribeiro J, Galas F, Gaiotto F, Lisboa L, Fukushima J, Rizk S, Almeida J, Jatene F, Osawa E, Franco R, Kalil R, Hajjar L, Chlabicz M, Sobkowicz B, Kaminski K, Kazimierczyk R, Musial W, Tycińska A, Siranovic M, Gopcevic A, Gavranovic ZG, Horvat AH, Krolo H, Rode B, Videc L, Trifi A, Abdellatif S, Ismail KB, Bouattour A, Daly F, Nasri R, Lakhal SB, Beurton A, Teboul JL, Girotto V, Galarza L, Richard C, Monnet X, Beurton A, Teboul JL, Girotto V, Galarza L, Richard C, Monnet X, Girotto V, Teboul JL, Beurton A, Galarza L, Guedj T, Monnet X, Galarza L, Mercado P, Teboul JL, Girotto V, Beurton A, Richard C, Monnet X, Iliæ MK, Sakic L, NN V, Stojcic L, Jozwiak M, Depret F, Teboul JL, Alphonsine J, Lai C, Richard C, Monnet X, Tapanwong N, Chuntupama P, Wacharasint P, Huber W, Hoellthaler J, Lahmer T, Schmid R, Latham H, Bengtson CD, Satterwhite L, Stites M, Simpson SQ, Latham H, Bengtson CD, Satterwhite L, Stites M, Simpson SQ, Skladzien T, Cicio M, Garlicki J, Serednicki W, Wordliczek J, Vargas P, Salazar A, Mercado P, Espinoza M, Graf J, Kongpolprom N, Sanguanwong N, Jonnada S, Gerrard C, Jones N, Morley T, Thorburn PT, Trimmings A, Musaeva T, Zabolotskikh I, Salazar A, Vargas P, Mercado P, Espinoza M, Graf J, Horst S, Lipcsey M, Kawati R, Pikwer A, Rasmusson J, Castegren M, Shilova A, Yafarova A, Gilyarov M, Shilova A, Yafarova A, Gilyarov M, Stojiljkovic DLL, Ulici A, Reidt S, Lam T, Jancik J, Ragab D, Taema K, Farouk W, Saad M, Liu X, Holmberg MJ, Uber A, Montissol S, Donnino M, Andersen LW, Perlikos F, Lagiou M, Papalois A, Kroupis C, Toumpoulis I, Osawa E, Carter D, Sardo S, Almeida J, Galas F, Rizk S, Franco R, Hajjar L, Landoni G, Kongsayreepong S, Sungsiri R, Wongsripunetit P, Marchio P, Guerra-Ojeda S, Gimeno-Raga M, Mauricio MD, Valles SL, Aldasoro C, Jorda A, Aldasoro M, Vila JM, Borg UB, Neitenbach AM, García M, González PG, Romero MG, Orduña PS, Cano AG, Rhodes A, Grounds RM, Cecconi M, Lee C, Hatib F, Jian Z, Rinehart J, De Los Santos J, Canales C, Cannesson M, García MIM, Hatib F, Jian Z, Scheeren T, Jian Z, Hatib F, Pinsky M, Chantziara V, Vassi A, Michaloudis G, Sanidas E, Golemati S, Bateman RM, Mokhtar A, Omar W, Aziz KA, El Azizy H, Nielsen DLL, Holler JG, Lassen A, Eriksson M, Strandberg G, Lipcsey M, Larsson A, Capoletto C, Almeida J, Ferreira G, Fukushima J, Nakamura R, Risk S, Osawa E, Park C, Oliveira G, Galas F, Franco R, Hajjar L, Dias F, D’Arrigo N, Fortuna F, Redaelli S, Zerman L, Becker L, Serrano T, Cotes L, Ramos F, Fadel L, Coelho F, Mendes C, Real J, Pedron B, Kuroki M, Costa E, Azevedo L. 37th International Symposium on Intensive Care and Emergency Medicine (part 1 of 3). Crit Care 2017. [PMCID: PMC5374603 DOI: 10.1186/s13054-017-1628-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
6
|
Polo A, Duran J, Juanola R, Real J, Benet-Buchholz J, Solà M, Poater A. Tuning diastereoisomerism in platinum(ii) phosphino- and aminothiolato hydrido complexes. NEW J CHEM 2017. [DOI: 10.1039/c6nj04042j] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Tuning between the cis and trans Pt(ii) based complexes bearing phosphinothiolato and aminothiolato ligands.
Collapse
Affiliation(s)
- A. Polo
- Departament de Química
- Universitat de Girona
- Facultat de Ciències
- 17003 Girona
- Spain
| | - J. Duran
- Departament de Química
- Universitat de Girona
- Facultat de Ciències
- 17003 Girona
- Spain
| | - R. Juanola
- Departament de Química
- Universitat de Girona
- Facultat de Ciències
- 17003 Girona
- Spain
| | - J. Real
- Departament de Química
- Universitat Autònoma de Barcelona
- 08193 Bellaterra
- Spain
| | - J. Benet-Buchholz
- Institute of Chemical Research of Catalonia (ICIQ)
- 43007 Tarragona
- Spain
| | - M. Solà
- Departament de Química
- Universitat de Girona
- Facultat de Ciències
- 17003 Girona
- Spain
| | - A. Poater
- Departament de Química
- Universitat de Girona
- Facultat de Ciències
- 17003 Girona
- Spain
| |
Collapse
|
7
|
Muñoz M, Real J, Del Val J, Vinyoles E, Mundet X, Frigola-Capell E, Llauger M, Orfila F, Domingo M, Verdú-Rotellar J. Determinants of survival and hospitalization in older, heart failure patients receiving home healthcare. Int J Cardiol 2016; 207:145-9. [DOI: 10.1016/j.ijcard.2016.01.170] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Revised: 12/16/2015] [Accepted: 01/09/2016] [Indexed: 12/22/2022]
|
8
|
Real J, Cleries R, Forné C, Roso-Llorach A, Martínez-Sánchez JM. [Use of multiple regression models in observational studies (1970-2013) and requirements of the STROBE guidelines in Spanish scientific journals]. Semergen 2015; 42:523-529. [PMID: 26548318 DOI: 10.1016/j.semerg.2015.06.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Revised: 05/15/2015] [Accepted: 06/05/2015] [Indexed: 11/29/2022]
Abstract
BACKGROUND In medicine and biomedical research, statistical techniques like logistic, linear, Cox and Poisson regression are widely known. The main objective is to describe the evolution of multivariate techniques used in observational studies indexed in PubMed (1970-2013), and to check the requirements of the STROBE guidelines in the author guidelines in Spanish journals indexed in PubMed. METHODS A targeted PubMed search was performed to identify papers that used logistic linear Cox and Poisson models. Furthermore, a review was also made of the author guidelines of journals published in Spain and indexed in PubMed and Web of Science. RESULTS Only 6.1% of the indexed manuscripts included a term related to multivariate analysis, increasing from 0.14% in 1980 to 12.3% in 2013. In 2013, 6.7, 2.5, 3.5, and 0.31% of the manuscripts contained terms related to logistic, linear, Cox and Poisson regression, respectively. On the other hand, 12.8% of journals author guidelines explicitly recommend to follow the STROBE guidelines, and 35.9% recommend the CONSORT guideline. CONCLUSIONS A low percentage of Spanish scientific journals indexed in PubMed include the STROBE statement requirement in the author guidelines. Multivariate regression models in published observational studies such as logistic regression, linear, Cox and Poisson are increasingly used both at international level, as well as in journals published in Spanish.
Collapse
Affiliation(s)
- J Real
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, España; Facultat de Medicina i Ciències de la Salut, Universitat Intenacional de Catalunya, Sant Cugat, Barcelona, España
| | - R Cleries
- Pla Director d'Oncologia de Catalunya, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España; Departament de Ciències Clíniques, Universitat de Barcelona, Campus de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España
| | - C Forné
- Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Lleida, España; Oblikue Consulting, Barcelona, España
| | - A Roso-Llorach
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, España; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, España
| | - J M Martínez-Sánchez
- Facultat de Medicina i Ciències de la Salut, Universitat Intenacional de Catalunya, Sant Cugat, Barcelona, España; Unitat de Control del Tabaquisme, Programa de Prevenció i Control del Càncer, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España; Grup de Prevenció i Control del Càncer, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
| |
Collapse
|
9
|
Larrodé I, Idoipe A, Bernabé S, Pascual O, Uriarte M, Real J. CPC-057 Evolution of Clinical Trial Prescribing Incidents. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
10
|
Aamodt K, Abelev B, Quintana AA, Adamová D, Adare AM, Aggarwal MM, Rinella GA, Agocs AG, Salazar SA, Ahammed Z, Masoodi AA, Ahmad N, Ahn SU, Akindinov A, Aleksandrov D, Alessandro B, Molina RA, Alici A, Alkin A, Aviña EA, Alt T, Altini V, Altinpinar S, Altsybeev I, Andrei C, Andronic A, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Ferroli RB, Baldisseri A, Baldit A, Pedrosa FBDS, Bán J, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Beck H, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Bergmann C, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Bombonati C, Book J, Borel H, Borissov A, Bortolin C, Bose S, Bossú F, Botje M, Böttger S, Boyer B, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Broz M, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Bugaiev K, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Villar EC, Camerini P, Canoa Roman V, Romeo GC, Carena F, Carena W, Carminati F, Díaz AC, Caselle M, Castellanos JC, Catanescu V, Cavicchioli C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Barroso VC, Chinellato DD, Chochula P, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Coccetti F, Coffin JP, Coli S, Balbastre GC, del Valle ZC, Constantin P, Contin G, Contreras JG, Cormier TM, Morales YC, Maldonado IC, Cortese P, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Erasmo GD, Dainese A, Dalsgaard HH, Danu A, Das D, Das I, Das K, Dash A, Dash S, De S, Moregula ADA, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, Debski PR, Sanchez EDC, Delagrange H, Mercado YD, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dietel T, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Domínguez I, Dönigus B, Dordic O, Driga O, Dubey AK, Dubuisson J, Ducroux L, Dupieux P, Majumdar AKD, Majumdar MRD, Elia D, Emschermann D, Engel H, Erdal HA, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Feofilov G, Téllez AF, Ferretti A, Ferretti R, Figiel J, Figueredo MAS, Filchagin S, Fini R, Finogeev D, Fionda FM, Fiore EM, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Fuchs U, Furano F, Furget C, Girard MF, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Gangadharan DR, Ganoti P, Ganti MS, Garabatos C, Garcia-Solis E, Garishvili I, Gemme R, Gerhard J, Germain M, Geuna C, Gheata A, Gheata M, Ghidini B, Ghosh P, Gianotti P, Girard MR, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez R, Ferreiro EG, Santos HG, González-Trueba LH, González-Zamora P, Gorbunov S, Gotovac S, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Gutierrez CG, Guerzoni B, Gulbrandsen K, Gunji T, Gupta A, Gupta R, Gutbrod H, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Harris JW, Hartig M, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Corral GH, Herrmann N, Hetland KF, Hicks B, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hřivnáčová I, Huang M, Huber S, Humanic TJ, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Incani E, Innocenti GM, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jancurová L, Jangal S, Janik R, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kalcher S, Kaliňák P, Kalisky M, Kalliokoski T, Kalweit A, Kamermans R, Kanaki K, Kang E, Kang JH, Kaplin V, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim JH, Kim JS, Kim M, Kim M, Kim S, Kim SH, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Koch K, Köhler MK, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Don CKK, Kour R, Kowalski M, Kox S, Meethaleveedu GK, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Krawutschke T, Kretz M, Krivda M, Krizek F, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kushpil V, Kweon MJ, Kwon Y, La Rocca P, Ladrón de Guevara P, Lafage V, Lara C, Lardeux A, Larsen DT, Lazzeroni C, Le Bornec Y, Lea R, Lee KS, Lee SC, Lefèvre F, Lehnert J, Leistam L, Lenhardt M, Lenti V, Monzón IL, Vargas HL, Lévai P, Li X, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loenne PI, Loggins VR, Loginov V, Lohn S, Loizides C, Loo KK, Lopez X, Noriega ML, Torres EL, Løvhøiden G, Lu XG, Luettig P, Lunardon M, Luparello G, Luquin L, Luzzi C, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Mal'Kevich D, Malaev M, Cervantes IM, Malinina L, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Martashvili I, Martinengo P, Martínez MI, Davalos AM, García GM, Martynov Y, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mayer C, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Lorenzo PM, Menis I, Pérez JM, Meres M, Mereu P, Miake Y, Midori J, Milano L, Milosevic J, Mischke A, Miśkowiec D, Mitu C, Mlynarz J, Mohanty AK, Mohanty B, Molnar L, Zetina LM, Monteno M, Montes E, Morando M, De Godoy DAM, Moretto S, Morsch A, Muccifora V, Mudnic E, Muhuri S, Müller H, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Nattrass C, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nicassio M, Nielsen BS, Niida T, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nooren G, Novitzky N, Nyanin A, Nyatha A, Nygaard C, Nystrand J, Obayashi H, Ochirov A, Oeschler H, Oh SK, Oleniacz J, Oppedisano C, Velasquez AO, Ortona G, Oskarsson A, Ostrowski P, Otterlund I, Otwinowski J, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Jayarathna SP, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Pappalardo GS, Park WJ, Patalakha DI, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Peresunko D, Lara CEP, Perini D, Perrino D, Peryt W, Pesci A, Peskov V, Pestov Y, Peters AJ, Petráček V, Petran M, Petris M, Petrov P, Petrovici M, Petta C, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Piyarathna DB, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Polák K, Polichtchouk B, Pop A, Porteboeuf S, Pospíšil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pulvirenti A, Punin V, Putiš M, Putschke J, Quercigh E, Qvigstad H, Rachevski A, Rademakers A, Rademakers O, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Reyes AR, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Read KF, Real J, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Cahuantzi MR, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Montero AJR, Rui R, Rivetti A, Rusanov I, Ryabinkin E, Rybicki A, Sadovsky S, Safařík K, Sahoo R, Sahu PK, Saini J, Saiz P, Sakai S, Sakata D, Salgado CA, Samanta T, Sambyal S, Samsonov V, Castro XS, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Scott R, Segato G, Selyuzhenkov I, Senyukov S, Seo J, Serci S, Serradilla E, Sevcenco A, Sgura I, Shabratova G, Shahoyan R, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siemiarczuk T, Silenzi A, Silvermyr D, Simonetti G, Singaraju R, Singh R, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Søgaard C, Soloviev A, Soltz R, Son H, Song J, Song M, Soos C, Soramel F, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Stefanini G, Steinbeck T, Steinpreis M, Stenlund E, Steyn G, Stocco D, Stock R, Stokkevag CH, Stolpovskiy M, Strmen P, Suaide AAP, Vásquez MAS, Sugitate T, Suire C, Sukhorukov M, Sumbera M, Susa T, Swoboda D, Symons TJM, de Toledo AS, Szarka I, Szostak A, Tagridis C, Takahashi J, Takaki JDT, Tauro A, Tavlet M, Muñoz GT, Telesca A, Terrevoli C, Thäder J, Thomas D, Thomas JH, Tieulent R, Timmins AR, Tlusty D, Toia A, Torii H, Toscano L, Tosello F, Traczyk T, Truesdale D, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Turvey AJ, Tveter TS, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vajzer M, Vala M, Palomo LV, Vallero S, van der Kolk N, van Leeuwen M, Vande Vyvre P, Vannucci L, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Venaruzzo M, Vercellin E, Vergara S, Vernekohl DC, Vernet R, Verweij M, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Baillie OV, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Øvrebekk G, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner V, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk A, Wilk G, Williams MCS, Windelband B, Karampatsos LX, Yang H, Yang S, Yasnopolskiy S, Yi J, Yin Z, Yokoyama H, Yoo IK, Yu W, Yuan X, Yushmanov I, Zabrodin E, Zach C, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zelnicek P, Zenin A, Zgura I, Zhalov M, Zhang X, Zhou D, Zichichi A, Zinovjev G, Zoccarato Y, Zynovyev M. Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010; 105:252302. [PMID: 21231580 DOI: 10.1103/physrevlett.105.252302] [Citation(s) in RCA: 84] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2010] [Indexed: 05/30/2023]
Abstract
We report the first measurement of charged particle elliptic flow in Pb-Pb collisions at sqrt[S(NN)] =2.76 TeV with the ALICE detector at the CERN Large Hadron Collider. The measurement is performed in the central pseudorapidity region (|η|<0.8) and transverse momentum range 0.2<p t<5.0 GeV/c. The elliptic flow signal v₂, measured using the 4-particle correlation method, averaged over transverse momentum and pseudorapidity is 0.087 ± 0.002(stat) ± 0.003(syst) in the 40%-50% centrality class. The differential elliptic flow v₂ p t reaches a maximum of 0.2 near p t =3 GeV/c. Compared to RHIC Au-Au collisions at sqrt[S(NN)] 200 GeV, the elliptic flow increases by about 30%. Some hydrodynamic model predictions which include viscous corrections are in agreement with the observed increase.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Aamodt K, Abelev B, Quintana AA, Adamová D, Adare AM, Aggarwal MM, Rinella GA, Agocs AG, Salazar SA, Ahammed Z, Masoodi AA, Ahmad N, Ahn SU, Akindinov A, Aleksandrov D, Alessandro B, Molina RA, Alici A, Alkin A, Aviña EA, Alt T, Altini V, Altinpinar S, Altsybeev I, Andrei C, Andronic A, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Ferroli RB, Baldisseri A, Baldit A, Pedrosa FBDS, Bán J, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Beck H, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Bergmann C, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Bombonati C, Book J, Borel H, Borissov A, Bortolin C, Bose S, Bossú F, Botje M, Böttger S, Boyer B, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Broz M, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Bugaiev K, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Villar EC, Camerini P, Roman VC, Romeo GC, Carena F, Carena W, Carminati F, Díaz AC, Caselle M, Castellanos JC, Catanescu V, Cavicchioli C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Barroso VC, Chinellato DD, Chochula P, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Coccetti F, Coffin JP, Coli S, Balbastre GC, Del Valle ZC, Constantin P, Contin G, Contreras JG, Cormier TM, Morales YC, Maldonado IC, Cortese P, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Erasmo GD, Dainese A, Dalsgaard HH, Danu A, Das D, Das I, Das K, Dash A, Dash S, De S, Moregula ADA, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, Debski PR, Sanchez EDC, Delagrange H, Mercado YD, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dietel T, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Domínguez I, Dönigus B, Dordic O, Driga O, Dubey AK, Dubuisson J, Ducroux L, Dupieux P, Majumdar AKD, Majumdar MRD, Elia D, Emschermann D, Engel H, Erdal HA, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Feofilov G, Téllez AF, Ferretti A, Ferretti R, Figiel J, Figueredo MAS, Filchagin S, Fini R, Finogeev D, Fionda FM, Fiore EM, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Fuchs U, Furano F, Furget C, Girard MF, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Gangadharan DR, Ganoti P, Ganti MS, Garabatos C, Garcia-Solis E, Garishvili I, Gemme R, Gerhard J, Germain M, Geuna C, Gheata A, Gheata M, Ghidini B, Ghosh P, Gianotti P, Girard MR, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez R, Ferreiro EG, Santos HG, González-Trueba LH, González-Zamora P, Gorbunov S, Gotovac S, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Gutierrez CG, Guerzoni B, Gulbrandsen K, Gunji T, Gupta A, Gupta R, Gutbrod H, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Harris JW, Hartig M, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Corral GH, Herrmann N, Hetland KF, Hicks B, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hřivnáčová I, Huang M, Huber S, Humanic TJ, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Incani E, Innocenti GM, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jancurová L, Jangal S, Janik R, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kalcher S, Kaliňák P, Kalisky M, Kalliokoski T, Kalweit A, Kamermans R, Kanaki K, Kang E, Kang JH, Kaplin V, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim JH, Kim JS, Kim M, Kim M, Kim S, Kim SH, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Koch K, Köhler MK, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Don CKK, Kour R, Kowalski M, Kox S, Meethaleveedu GK, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Krawutschke T, Kretz M, Krivda M, Krizek F, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kushpil V, Kweon MJ, Kwon Y, La Rocca P, de Guevara PL, Lafage V, Lara C, Lardeux A, Larsen DT, Lazzeroni C, Le Bornec Y, Lea R, Lee KS, Lee SC, Lefèvre F, Lehnert J, Leistam L, Lenhardt M, Lenti V, Monzón IL, Vargas HL, Lévai P, Li X, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loenne PI, Loggins VR, Loginov V, Lohn S, Loizides C, Loo KK, Lopez X, Noriega ML, Torres EL, Løvhøiden G, Lu XG, Luettig P, Lunardon M, Luparello G, Luquin L, Luzzi C, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Mal'Kevich D, Malaev M, Cervantes IM, Malinina L, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Martashvili I, Martinengo P, Martínez MI, Davalos AM, García GM, Martynov Y, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mayer C, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Lorenzo PM, Menis I, Pérez JM, Meres M, Mereu P, Miake Y, Midori J, Milano L, Milosevic J, Mischke A, Miśkowiec D, Mitu C, Mlynarz J, Mohanty AK, Mohanty B, Molnar L, Zetina LM, Monteno M, Montes E, Morando M, De Godoy DAM, Moretto S, Morsch A, Muccifora V, Mudnic E, Muhuri S, Müller H, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Nattrass C, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nicassio M, Nielsen BS, Niida T, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nooren G, Novitzky N, Nyanin A, Nyatha A, Nygaard C, Nystrand J, Obayashi H, Ochirov A, Oeschler H, Oh SK, Oleniacz J, Oppedisano C, Velasquez AO, Ortona G, Oskarsson A, Ostrowski P, Otterlund I, Otwinowski J, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Jayarathna SP, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Pappalardo GS, Park WJ, Patalakha DI, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Peresunko D, Lara CEP, Perini D, Perrino D, Peryt W, Pesci A, Peskov V, Pestov Y, Peters AJ, Petráček V, Petran M, Petris M, Petrov P, Petrovici M, Petta C, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Piyarathna DB, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Polák K, Polichtchouk B, Pop A, Porteboeuf S, Pospíšil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pulvirenti A, Punin V, Putiš M, Putschke J, Quercigh E, Qvigstad H, Rachevski A, Rademakers A, Rademakers O, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Ramírez Reyes A, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Read KF, Real J, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Cahuantzi MR, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Montero AJR, Rui R, Rivetti A, Rusanov I, Ryabinkin E, Rybicki A, Sadovsky S, Safařík K, Sahoo R, Sahu PK, Saini J, Saiz P, Sakai S, Sakata D, Salgado CA, Samanta T, Sambyal S, Samsonov V, Castro XS, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Scott R, Segato G, Selyuzhenkov I, Senyukov S, Seo J, Serci S, Serradilla E, Sevcenco A, Sgura I, Shabratova G, Shahoyan R, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siemiarczuk T, Silenzi A, Silvermyr D, Simonetti G, Singaraju R, Singh R, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Søgaard C, Soloviev A, Soltz R, Son H, Song J, Song M, Soos C, Soramel F, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Stefanini G, Steinbeck T, Steinpreis M, Stenlund E, Steyn G, Stocco D, Stock R, Stokkevag CH, Stolpovskiy M, Strmen P, Suaide AAP, Vásquez MAS, Sugitate T, Suire C, Sukhorukov M, Sumbera M, Susa T, Swoboda D, Symons TJM, de Toledo AS, Szarka I, Szostak A, Tagridis C, Takahashi J, Takaki JDT, Tauro A, Tavlet M, Muñoz GT, Telesca A, Terrevoli C, Thäder J, Thomas D, Thomas JH, Tieulent R, Timmins AR, Tlusty D, Toia A, Torii H, Toscano L, Tosello F, Traczyk T, Truesdale D, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Turvey AJ, Tveter TS, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vajzer M, Vala M, Palomo LV, Vallero S, van der Kolk N, van Leeuwen M, Vande Vyvre P, Vannucci L, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Venaruzzo M, Vercellin E, Vergara S, Vernekohl DC, Vernet R, Verweij M, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Baillie OV, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Øvrebekk G, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner V, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk A, Wilk G, Williams MCS, Windelband B, Karampatsos LX, Yang H, Yang S, Yasnopolskiy S, Yi J, Yin Z, Yokoyama H, Yoo IK, Yu W, Yuan X, Yushmanov I, Zabrodin E, Zach C, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zelnicek P, Zenin A, Zgura I, Zhalov M, Zhang X, Zhou D, Zichichi A, Zinovjev G, Zoccarato Y, Zynovyev M. Charged-particle multiplicity density at midrapidity in central Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010; 105:252301. [PMID: 21231579 DOI: 10.1103/physrevlett.105.252301] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2010] [Indexed: 05/30/2023]
Abstract
The first measurement of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at a center-of-mass energy per nucleon pair √ S NN = 2.76 TeV is presented. For an event sample corresponding to the most central 5% of the hadronic cross section, the pseudorapidity density of primary charged particles at midrapidity is 1584 ± 4(stat) ± 76(syst), which corresponds to 8.3 ± 0.4(syst) per participating nucleon pair. This represents an increase of about a factor 1.9 relative to pp collisions at similar collision energies, and about a factor 2.2 to central Au-Au collisions at √ S NN = 2.76 TeV. This measurement provides the first experimental constraint for models of nucleus-nucleus collisions at LHC energies.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Serna MC, Cruz I, Real J, Gascó E, Galván L. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiatry 2009; 25:206-13. [PMID: 20005684 DOI: 10.1016/j.eurpsy.2009.07.012] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2009] [Revised: 07/15/2009] [Accepted: 07/20/2009] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND Many patients discontinue antidepressant therapy long before the six-month minimum duration recommended for the treatment of major depression and many other diagnoses. PURPOSE To estimate the duration of antidepressant treatment and to analyse the following factors in relation to treatment adherence: age, sex, polypharmacy and type of drug. METHODS Retrospective cohort followed up for five years (2003-2007) based on prescription database. SELECTION CRITERIA Users who had received at least one antidepressant prescription in 2003 and who had not received antidepressants during the previous 12 months. VARIABLES STUDIED Age, sex, drug, polypharmacy, period of treatment, packs dispensed. Adequate adherence was defined as dispensation of medication during at least 80% of the treatment period, and compliance was defined as good when, in addition, the treatment lasted more than four months. RESULTS Of the 7525 patients selected, 56% abandoned medication during the first four months. Men were more likely to give up medication before time than women. Good compliance was recorded in 22% of patients and was twice as frequent in patients with high levels of polypharmacy than in those with low levels (31% vs. 15.3%). Patients receiving maprotiline, venlafaxine, mirtazapine, citalopram, clomipramine and fluoxetine presented the highest percentages of good compliance. CONCLUSIONS Only one out of five patients complied with treatment for over four months. Treatment periods were shorter in men. In chronic processes, patients receiving polypharmacy presented the best compliance.
Collapse
Affiliation(s)
- M C Serna
- Regional Primary Care Management Office, Catalan Institute of Health, University of Lleida, Lleida, Spain
| | | | | | | | | |
Collapse
|
13
|
Real J, Marques M, Spilborghs G, Negri E, Matzuk M, Moura R, Camargo A, Deheinzelin D, Dias A. The role of the acute phase protein PTX3 in the ventilator-induced lung injury. Eur Respir Rev 2008. [DOI: 10.1183/09059180.00010807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
14
|
Martinez-Hervas S, Romero P, Ferri J, Benito E, Priego A, Real J, Carmena R, Ascaso J. WAIST CIRCUMFERENCE AND ATHEROGENIC DYSLIPIDEMIA. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70919-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
15
|
Abellan R, Martinez-Hervas S, Pedro T, Real J, Garcia-Garcia A, Chaves F, Saez-Merino G, Carmena R, Ascaso J. ANTIOXIDATIVE STRESS SYSTEMS IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)71068-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Vallés J, Pobo A, García-Esquirol O, Mariscal D, Real J, Fernández R. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007; 33:1363-8. [PMID: 17558495 DOI: 10.1007/s00134-007-0721-0] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2006] [Accepted: 04/06/2007] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To determine the impact of ventilator-associated pneumonia (VAP) on ICU mortality, and whether it is related to time of onset of pneumonia. DESIGN Prospective cohort study. SETTING 16-bed medical-surgical ICU at a university-affiliated hospital. PATIENTS AND MEASUREMENTS From 2002 to 2003, we recorded patients receiving mechanical ventilation for > 72 h. Patients developing an infection other than VAP were excluded. Patients definitively diagnosed with VAP (n=40) were cases and patients free of any infection acquired during ICU stay (n=61) were controls. The VAP-attributed mortality was defined as the difference between observed mortality and predicted mortality (SAPS II) on admission. RESULTS Mechanical ventilation was longer in VAP patients (25 +/- 20 vs 11 +/- 9 days; p < 0.001), as was ICU stay (33 +/- 23 vs 14 +/- 12 days; p < 0.001). In the non-VAP group, no difference was found between observed and predicted mortality (27.9 vs 27.4%; p > 0.2). In the VAP group, observed mortality was 45% and predicted mortality 26.5% (p < 0.001), with attributable mortality 18.5%, and relative risk (RR) 1.7 (95% CI 1.12-23.17). No difference was observed between observed and predicted mortality in early-onset VAP (27.3 vs 25.8%; p > 0.20); in late-onset VAP, observed mortality was higher (51.7 vs 26.7%; p < 0.01) with attributable mortality of 25% and an RR 1.9 (95% CI 1.26-2.63). Empiric antibiotic treatment was appropriate in 77.5% of episodes. No differences in mortality were related to treatment appropriateness. CONCLUSIONS In mechanically ventilated patients, VAP is associated with excess mortality, mostly restricted to late-onset VAP and despite appropriate antibiotic treatment.
Collapse
Affiliation(s)
- J Vallés
- Hospital Parc Tauli, Critical Care Center, Parc Tauli s/n, 08208 Sabadell, Spain.
| | | | | | | | | | | |
Collapse
|
17
|
Rodríguez Jornet A, Ibeas J, Real J, Peña S, Martínez Ocaña JC, García García M. [Advance directives in chronic dialysis patients]. Nefrologia 2007; 27:581-592. [PMID: 18045034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023] Open
Abstract
BACKGROUND AND OBJECTIVE Knowledge of the life-sustaining treatment preferences of the dialysis patients would be extremely helpful to substitute decision-makers and nephrologists in deciding whether to continue or stop a treatment. The population of the Mediterranean countries show this opinion with less frequency. The objective of this study is: 1) the knowledge of the patient's view for the advance directives; it may increase the likelihood to get the correct decisions of the staff when complications break the normal course of chronic dialysis, and 2) the statement of the advance directives. MATERIAL AND METHOD We distributed 135 questionnaires to patients with chronic renal failure in dialysis treatment of the Sabadell's Hospital to explore demographic information about responders and not-responders and explore the rate of questionnaires was completed about the cardiopulmonary resuscitation, respirator, tube feeding and dialysis in case of coma, persistent vegetative state, severe dementia and terminal illness. We explore about the representative of patients and in case of not-responders about the cause to not answer. RESULTS Sixty-four of 135 patients (47,8%) did not want cardiopulmonary resuscitation, respirator, tube feeding or dialysis in case of coma, persistent vegetative state, severe dementia or terminal illness. Compared with patients who wanted the treatments, those who did not were older (71,2 versus 62,2 years; p = 0.002). There was no difference in the other demographic questions, including sex (p=0.674), cause of kidney failure (p=0.815), comorbid conditions (p=0.824), and social status (language of questionnaire -0.155- and standard of education -0.288-). Advance care planning does not occur solely within the context of the physician-patient relationship; the respondents reported the representative in the family, essentially. The patients not-responders doesn t want to think in those situations and also they show doubt about the interpretation of their answers. CONCLUSIONS near 50% patients in chronic dialysis want to stop certain treatments in case of resuscitation cardiopulmonary, coma, persistent vegetative state, severe dementia or terminal illness. The older patients want the limitation of treatments more frequently.
Collapse
|
18
|
Gratacós J, Casado E, Real J, Torre-Alonso JC. Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate. Ann Rheum Dis 2006; 66:493-7. [PMID: 17179176 PMCID: PMC1856049 DOI: 10.1136/ard.2006.060079] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To determine the predictive factors of clinical response to infliximab in patients with refractory psoriatic polyarthritis. METHODS A multicentre open study which included 69 patients with psoriatic polyarthritis refractory to methotrexate (15 mg/week at least for 8 weeks). Patients were treated with infliximab 5 mg/kg every 8 weeks in addition to their stable doses of methotrexate. A major clinical response was defined by the ACR50 at week 38. Logistic regression analysis was performed to analyse which of the following measures at the start of treatment were associated with an ACR50 response: demographic and clinical characteristics, duration of disease, tender and swollen joint counts, involvement of large joints (knee or hip, or both), erythrocyte sedimentation rate, C reactive protein (CRP), Health Assessment Questionnaire disability index, axial involvement, and the presence of erosions at baseline. RESULTS In an intention to treat analysis 30/69 (44%) patients achieved an ACR50 response. In the univariate analysis both the presence of large joint involvement and severe disability were associated with a poor clinical response. In a multivariate logistic regression analysis high CRP values were independently associated with a good therapeutic response (odds ratio (OR)=18.7; 95% confidence interval (CI) 1.8 to 181.6; p=0.011). In contrast, large joint involvement and severe disability were associated with a poor response, which reached significance for large joint involvement (OR=29.3; 95% CI 3.2 to 266.3; p=0.003). CONCLUSION A lower disability and, in particular, the absence of large joint involvement and higher CRP serum levels at the start of infliximab treatment are factors that seem to influence the probability of achieving a good therapeutic response in patients with psoriatic arthritis.
Collapse
Affiliation(s)
- J Gratacós
- Rheumatology Unit, University Institute Parc Taulí, Sabadell, Barcelona, and Rheumatology Department, Monte Naranco Hospital, Oviedo, Spain.
| | | | | | | |
Collapse
|
19
|
Casado E, Gratacós J, Tolosa C, Martínez JM, Ojanguren I, Ariza A, Real J, Sanjuán A, Larrosa M. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2005; 65:385-90. [PMID: 16096334 PMCID: PMC1798076 DOI: 10.1136/ard.2004.023200] [Citation(s) in RCA: 106] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To evaluate the prevalence and incidence of antimalarial myopathy in patients with rheumatic diseases treated with antimalarial drugs. METHODS Over a three year period, all patients with rheumatic diseases who were taking antimalarial drugs were studied. Serum muscle enzymes were assessed at the time of inclusion and every six months thereafter. Muscle strength, electromyography (EMG), and muscle biopsy were assessed in patients with a persistent muscle enzyme disturbances. RESULTS 119 patients were included (111 chloroquine, eight hydroxychloroquine). Of these, 22 (18.5%) had a persistent muscle enzyme disturbance: lactate dehydrogenase 19/22 (86%); creatine kinase 7/22 (32%), and aldolase 3/22 (14%). Findings of antimalarial myopathy were detected in 3/15 biopsied patients (20%) by light microscopy and in all 15 by electron microscopy. Eleven patients had myopathy at the time of inclusion (prevalence 9.2%) and four patients developed muscle injury during follow up (annual incidence 1.2%). Muscle weakness was observed in 8 of 15 patients with biopsy proven myopathy, giving a prevalence of clinical antimalarial myopathy of 6.7%. All these patients also had a myopathic pattern on electromyography. CONCLUSIONS The prevalence of antimalarial myopathy is higher than previously recognised when muscle enzyme determination is used as a screening method. When a persistent muscle enzyme disturbance is observed, clinical and electromyographic studies should be undertaken periodically to detect the development of clinical myopathy. In cases of clinical myopathy, an anatomical-pathological tissue study, including an ultrastructural study, is mandatory to confirm the diagnosis.
Collapse
Affiliation(s)
- E Casado
- Rheumatology Unit, Parc Taulí University Hospital, Parc Taulí s/n. 08208 Sabadell, Barcelona, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Capdevila-Brophy C, Artigas-Pallarés J, Ramirez-Mallafré A, López-Rosendo M, Real J, Obiols-Llandrich JE. [The neuropsychological phenotype of attention deficit hyperactivity disorder: are there differences among subtypes?]. Rev Neurol 2005; 40 Suppl 1:S17-23. [PMID: 15736082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
INTRODUCTION Recent studies suggest that the ADHD subtypes would be best conceptualized as separate clinical entities, based on their epidemiology, central and associate symptomatology. OBJECTIVES To determine the differences and similarities between subtypes in its associate symptomatology, specifically in the neuropsychological phenotype of executive dysfunction. PATIENTS AND METHODS A group of children between 6 and 14 years of age with a diagnosis of ADHD-innattentive subtype (DESAT, n = 20) and another with ADHD-combined subtype (COMB, n = 39). RESULTS Overall, the COMB subject sample displayed lower performance than DESAT group. Statistically significant differences were found in Kaufman-ABC-hands movement subtest, Wisconsin Card Sorting Test (WCST)-total error and WCST-conceptual level. CONCLUSIONS The subtypes differ significantly in measures or non verbal working memory, hindsight, foresight, and motor control. Both groups share a deficit in response output speed and verbal working memory. We hypothesized areas of cognitive superiority for each subtype: spatial memory for the inattentive and gestaltic composition for the combined. Results provide evidence to support quantitative and qualitative differences in the neuropsychological profile between the ADHD-innatentive and combined subtypes.
Collapse
Affiliation(s)
- C Capdevila-Brophy
- Universidad Autonoma de Barcelona, Facultad de Psicologia, 08193 Bellaterra, Espana.
| | | | | | | | | | | |
Collapse
|
21
|
Rodríguez Jornet A, Ibeas J, Ribera L, Real J, Perendreu J, Falcó J, Vallespín J, Allegué N, Giménez Gaibar A, García García M. [Ischemic renal disease: revascularization or conservative treatment?]. Nefrologia 2005; 25:258-68. [PMID: 16053007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/03/2023] Open
Abstract
Ischemic nephropathy is recognized as a distinct cause of renal insufficiency and it is defined as a significant reduction in glomerular filtration rate in patients with hemodynamically significant renovascular occlusive disease. We argue the epidemiologic and clinical manifestations of atherosclerotic renovascular disease, and we evaluate the pronostic agents. Published studies of the outcome of revascularization for renal-artery stenosis have been excellent, offering a durable patency and functional improvement but they have had numerous limitations. The atherosclerosis is a systemic disease and it provides the general prognosis of patients. We conclude that ischemic renal disease is a nephropathy of smoker men, with proteinuria excretion similar to nephropathy with unilateral stenosis. The age of patients is the clinical feature that decide the treatment: surgery, angioplasty/stent or medical management. Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularization and medically treated patients have proved that the advanced chronic renal insufficiency is associated with an unfavourable response of treatment of the ischemic nephropathy. But, in this nephropathy the revascularization can be the better therapy for selected patients. The revascularization with angioplasty/stent for patients with unilateral renal stenosis and chronic renal insufficiency has a doubtful effectiveness, as the chronic renal failure is result of nephroangiosclerosis.
Collapse
|
22
|
|
23
|
Campo R, Brullet E, Junquera F, Puig-Diví V, Vergara M, Calvet X, Marco J, Chuecos M, Sánchez A, Alcázar A, Ruiz M, Puig M, Real J. Sedación en la endoscopia digestiva. Resultados de una encuesta hospitalaria en Cataluña. Gastroenterología y Hepatología 2004; 27:503-7. [PMID: 15544734 DOI: 10.1016/s0210-5705(03)70516-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
INTRODUCTION The need for sedation is increasing in digestive endoscopy units (DEU). There are no data on the use of sedation in DEU in Catalonia (Spain). OBJECTIVE To evaluate the use of sedation in DEU in Catalonia. MATERIAL AND METHOD A questionnaire on the practice of sedation was designed and sent to the heads of medical and nursing staff of the DEU of 63 public and private hospitals in Catalonia. Two mailings were sent with an interval of three months between each. The questionnaire included 62 items on the characteristics of the hospital and the DEU, number of explorations, frequency of sedation use, drugs employed, participation of an anesthesiologist, use of monitoring, and complications. RESULTS Forty-four DEU (70%) corresponding to 31 public hospitals and 13 private hospitals completed the questionnaire. Evaluation of sedation patterns was based on 105,904 explorations performed in the various DEU (56,453 gastroscopies, 47,278 colonoscopies and 2,173 endoscopic retrograde cholangiopancreatographies (ERCP) in 2001. Sedation, sedation-analgesia or anesthesia was used in 17% of gastroscopies, 61% of colonoscopies and 100% of ERCP. Sedation was administered by an anesthesiologist in 7% of gastroscopies, 25% of colonoscopies and 38% of ERCP. Anesthesiologist administration was more frequent in private than in public centers (gastroscopies: 25% vs. 2%; colonoscopies: 57% vs. 9%, p < 0.001). No deaths associated with the use of sedation were reported. Eighty-nine percent of the DEU complied with standard recommendations for the practice of sedation. CONCLUSIONS In Catalonia, the use of sedation is highly variable, depending on the endoscopic procedure and the DEU. Use of sedation in infrequent in gastroscopy, fairly widespread in colonoscopy and routine in ERCP. Anesthesiologist administration is significantly more frequent in private hospitals. Most DEU follow standard sedation practices.
Collapse
Affiliation(s)
- R Campo
- Servicio de Aparato Digestivo, Corporació Parc Taulí, Sabadell, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Tai ES, Adiconis X, Ordovas JM, Carmena-Ramon R, Real J, Corella D, Ascaso J, Carmena R. Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia. Clin Genet 2003; 63:53-8. [PMID: 12519372 DOI: 10.1034/j.1399-0004.2003.630108.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Scavenger receptor, class B, type 1 (SRBI) is a promising candidate gene involved in the pathophysiology of atherosclerosis. We have examined the association of three common polymorphisms at the SRBI locus in 77 subjects who were heterozygous for familial hypercholesterolemia (FH). The alleles represented by polymorphisms in exon 1 and exon 8 were associated with variation in plasma concentrations of fasting triglyceride (TG). Mean plasma TG concentrations for homozygotes for the most common allele, and for heterozygotes and homozygotes for the less common allele were 85 +/- 6, 111 +/- 9 and 135 +/- 22 mg/dl (p = 0.011) for exon 1, and 96 +/- 11, 86 +/- 6 and 134 +/- 13 mg/dl (p = 0.007) for exon 8, after adjustment for age, sex and body mass index. In addition, the exon 8 polymorphism was associated with increased total cholesterol (320 +/- 15, 340 +/- 8 and 388 +/- 18 mg/dl, p = 0.015), very low density lipoprotein (VLDL) cholesterol (18 +/- 2.9, 15.7 +/- 1.6 and 33.4 +/- 3.9 mg/dl, p < 0.001) and low density lipoprotein (LDL) cholesterol (251 +/- 15, 270 +/- 8 and 312 +/- 10 mg/dl, p = 0.041) concentrations. In agreement with animal studies, our data also suggest a role for the SRBI in the metabolism of apolipoprotein B (apoB)-containing lipoproteins in humans. This pathway may constitute a backup mechanism to LDL receptor-mediated pathways for the catabolism of these lipoproteins, which could be particularly relevant in subjects with high levels of apoB-containing lipoproteins, such as those occurring in patients with FH.
Collapse
Affiliation(s)
- E S Tai
- Nutrition and Genomics Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Calvet X, Quesada M, Sanfeliu I, Montserrat A, Brullet E, Real J, Segura F, Campo R. Evaluación de un test rápido (ImmunoCard STAT! HpSA) para la detección de Helicobacter pylori en heces. Gastroenterología y Hepatología 2003; 26:531-4. [PMID: 14642238 DOI: 10.1016/s0210-5705(03)70407-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION The use of a rapid diagnostic technique may be extremely useful for the management of Helicobacter pylori infection. A new immunochromatographic in-office test (ImmunoCard STAT! HpSA, Meridian Diagnosis Inc, Cincinnati, Ohio, USA) for the detection of H. pylori in feces has recently become available. The aim of the present study was to evaluate the diagnostic reliability and reproducibility of the ImmunoCard STAT! HpSA test in patients with dyspepsia. PATIENTS AND METHODS Sixty-three dyspeptic patients were enrolled. H. pylori status was determined by CLO-test and Giemsa staining of antral biopsy. Patients with a positive result for both tests were considered infected and those with a negative result for both tests were considered not infected. Fecal H. pylori antigen was tested twice by ImmunoCard STAT! HpSA. The sensitivity, specificity, positive predictive value and negative predictive value of each determination were calculated. The concordance between the two determinations was evaluated using Kappa statistics. RESULTS Of the 63 patients, 46 were infected by H. pylori. Sensitivity, specificity and positive and negative predictive values were 89-91%, 86-93%, 96-98% and 72-75%, respectively. The correlation coefficient between determinations was 0.845. CONCLUSION The new ImmunoCard STAT! HpSA test shows good sensitivity and reproducibility. Therefore, it could be highly useful in the management of H. pylori infection.
Collapse
Affiliation(s)
- X Calvet
- Unidad de Enfermedades Digestivas, Hospital de Sabadell, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Barcelona, España.
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
The radioactive isotopes of cesium and strontium may be deposited on urban surfaces in the case of an accidental atmospheric discharge from a nuclear facility and thus imply a health hazard. In order to handle the decontamination of these surfaces, we have carried out experiments under controlled conditions on tiles and concrete and we have studied.the physical and chemical mechanisms at the solid-liquid interface. The deposition of radionuclides was carried out in the form of aerosols indicating an accidental source term. Their desorption by rainwater is low in all cases, of the order of 5-6% for cesium for any material and 29 and 12% for strontium on tile and concrete, respectively. The low desorption values of cesium may be explained by the strong bonding that occurs with the silicates constituting the tile due to virtually irreversible processes of exchange of ions and by the formation of insoluble complexes with the C--S-H gel of concrete. The strontium-tile bonds are weaker, while strontium precipitates with the carbonates of concrete in the form of SrCO3. In view of these characteristics, washing solutions with high concentrations of chloride and oxalate of ammonium chosen for their ion-exchanging and sequestering properties were tested on these surfaces. The desorption of cesium improved strongly since it reached 70% on tile and 90% on concrete after 24h of contact, which is consistent with our knowledge of the; bonds between this element and the surfaces. Strontium, given the greater complexity of physical and chemical forms that it may take is less well desorbed. The ammonium chloride improves the desorption (50% and 40%, for tile and concrete, respectively) but the oxalate, while it does not affect desorption on the tiles, decreases that on the concrete since by strongly etching the concrete, it causes the release of carbonate ions that precipitate with strontium.
Collapse
Affiliation(s)
- J Real
- Department of Environmental Protection, Institute of Protection and Nuclear Safety, Saint-Paul-Lez-Durance, France.
| | | | | |
Collapse
|
27
|
Abstract
During 1980-97, trichomoniasis was detected in nestlings of Bonelli's eagle Hieraaetus fasciatus in Catalonia (Spain). In 1993 Trichomonas gallinae was isolated in 36% of nestlings (n = 39) and affected 41% of broods (n = 22). Overall, trichomoniasis was one of the most important single nestling mortality factor, accounting for 22% of total chick mortality, and causing the death of 2% of chicks. Trichomoniasis deaths took place during the second half of the nestling period. The median age at death was 45.5 days. Although the presence of the parasite was not related to the composition of the diet or parental age, pairs that developed the disease ate more pigeons and included more often non-adult birds. At present trichomoniasis apparently has little demographic impact on the Bonelli's eagle population in Catalonia, but the eventual spread of this disease in chicks and its unknown effects on adults might be of concern.
Collapse
Affiliation(s)
- J Real
- Departament de Biologia Animal (Vertebrats), Facultát de Biologia, Universitat de Barcelona, Catalonia, Spain.
| | | | | |
Collapse
|
28
|
Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P, Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22:352-5. [PMID: 10431238 DOI: 10.1038/11921] [Citation(s) in RCA: 1079] [Impact Index Per Article: 43.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Tangier disease (TD) was first discovered nearly 40 years ago in two siblings living on Tangier Island. This autosomal co-dominant condition is characterized in the homozygous state by the absence of HDL-cholesterol (HDL-C) from plasma, hepatosplenomegaly, peripheral neuropathy and frequently premature coronary artery disease (CAD). In heterozygotes, HDL-C levels are about one-half those of normal individuals. Impaired cholesterol efflux from macrophages leads to the presence of foam cells throughout the body, which may explain the increased risk of coronary heart disease in some TD families. We report here refining of our previous linkage of the TD gene to a 1-cM region between markers D9S271 and D9S1866 on chromosome 9q31, in which we found the gene encoding human ATP cassette-binding transporter 1 (ABC1). We also found a change in ABC1 expression level on cholesterol loading of phorbol ester-treated THP1 macrophages, substantiating the role of ABC1 in cholesterol efflux. We cloned the full-length cDNA and sequenced the gene in two unrelated families with four TD homozygotes. In the first pedigree, a 1-bp deletion in exon 13, resulting in truncation of the predicted protein to approximately one-fourth of its normal size, co-segregated with the disease phenotype. An in-frame insertion-deletion in exon 12 was found in the second family. Our findings indicate that defects in ABC1, encoding a member of the ABC transporter superfamily, are the cause of TD.
Collapse
Affiliation(s)
- S Rust
- Institut für Arterioskleroseforschung an der Westfälischen Wilhelms-Universität Münster, Germany.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Morillas C, Riera C, Meliá C, Solá E, Sanchez J, Real J, Muñoz M, Peña H, Hernández A. Cardiovascular risk factors in ischemic heart disease and in general population. Atherosclerosis 1999. [DOI: 10.1016/s0021-9150(99)80527-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Carmena-Ramon RF, Ordovas JM, Ascaso JF, Real J, Priego MA, Carmena R. Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familial hypercholesterolemia. Atherosclerosis 1998; 139:107-13. [PMID: 9699897 DOI: 10.1016/s0021-9150(98)00064-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We have examined the apo AI - 75 (G/A) and apo AI + 83(MspI +/-) polymorphisms at the APOA1 gene locus for associations with plasma lipid levels and response to an NCEP-I diet in 69 (44 women, 25 men) heterozygotes for familial hypercholesterolemia (FH). Subjects were studied at baseline (after consuming for one month a diet with 35%, fat, 10% saturated, and 300 mg/day cholesterol) and after 3 months of an NCEP-I diet. No gender-related differences for any of the lipid variables examined were found and the data were analyzed for men and women combined. For the apo AI - 75 (G/A) polymorphism, there were 51 G/G and 18 G/A subjects. At baseline, G/A subjects showed significantly lower total cholesterol (p = 0.0036), and LDL-C (p = 0.0023), and apo B (p = 0.0209), than G/G individuals, but no differences were found for HDL-C, triglycerides and VLDL-C values. Following the NCEP-I diet these genotype-related differences remained significant for total and LDL-C. The MspI (-) allele at the apo AI + 83 polymorphism was detected in the heterozygous state in five subjects and its presence was not associated with altered baseline lipids nor with dietary response to the NCEP-I diet. Our results suggest that FH subjects carrying the A allele at the apoAI - 75 (G/A) polymorphism have significantly lower total and LDL-C and apo B baseline levels but respond to a low-fat diet with similar reductions in total and LDL-C when compared with homozygotes for the G allele at this polymorphic site.
Collapse
Affiliation(s)
- R F Carmena-Ramon
- Department of Medicine, Hospital Clinico, University of Valencia, Spain
| | | | | | | | | | | |
Collapse
|
31
|
Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martinez-Valls J, Carmena R. Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia. Int J Obes (Lond) 1997; 21:360-6. [PMID: 9152737 DOI: 10.1038/sj.ijo.0800413] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The influence of obesity on blood pressure and plasma lipoproteins, glucose and insulin levels was investigated in patients with familial combined hyperlipidaemia (FCH). Sixty seven FCH patients mean age 49.0 +/- 8.9 y (45 male, 22 female) defined as obese (BMI > or = 27 kg/m2, n = 39) or non-obese (BMI < 27 kg/m2, n = 28) were compared with control subjects matched for age, gender and body weight. Blood pressure, plasma lipoproteins, glucose and insulin were measured at baseline and following standard oral glucose load. The analysis indicate that FCH subjects with BMI > or = 27 kg/m2 had significantly higher systolic and diastolic blood pressure, blood glucose and insulin levels following oral glucose tolerance test than those with BMI < 27 kg/m2. Fasting plasma insulin values were also significantly higher in the BMI > or = 27kg/m2 subjects (138.5 +/- 66.6 vs 111.0 +/- 29.9 pmol/l, respectively, P < 0.05). Quantification of the area under the curve of the insulin secretion showed hyperinsulinaemia in 64.1% of patients with BMI > or = 27kg/m2 compared to 28.5% in the group with BMI < 27 kg/m2 (P < 0.01). Plasma insulin values were positively related to triglyceridaemia. There were no differences in the plasma lipid values between the two FCH groups. We conclude that fasting and post-glucose stimulated plasma insulin levels are frequent findings in patients with FCH when compared with control subjects of similar age, gender and BMI. Moreover, obesity (BMI > or = 27kg/m2) exacerbates the hyperglycaemia, hyperinsulinaemia and blood pressure values in these FCH subjects. These factors, together with lipid abnormalities, can predispose to the elevated risk of cardiovascular disease observed in FCH subjects.
Collapse
Affiliation(s)
- J F Ascaso
- Servicio de Endocrinología, Hospital Clínico Universitario, Universitad de Valencia, Spain
| | | | | | | | | | | | | |
Collapse
|
32
|
Puig O, Chaves FJ, García-Sogo M, Real J, Gil JV, Armengod ME. A three-allelic polymorphic system in exon 12 of the LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish population. Clin Genet 1996; 50:50-3. [PMID: 8891387 DOI: 10.1111/j.1399-0004.1996.tb02346.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
We have screened exon 12 of the low density lipoprotein (LDL) receptor gene from 46 familial hypercholesterolemia (FH) heterozygotes and 64 normolipidemic controls for two polymorphisms, HincII, which is caused by a T to C substitution at base 1773, and a C to T transition at base 1725, by using single strand conformation polymorphism (SSCP) analysis. Our results indicate that polymorphism at base 1725, previously reported as very rare from a Japanese sample, is quite frequent in the Spanish population and that it is closely linked to the presence of the HincII site (HincII+). Thus, both polymorphisms constitute a system of three alleles, typed HincII- C1725, HincII+ C1725, and HincII+ T1725, whose frequencies in the FH sample were 0.489, 0.347, and 0.164, respectively. No significant differences were found in the allele frequencies between the FH and control samples. This three-allelic polymorphic system provides a higher information content (PIC value) than the HincII RFLP alone (0.537 versus 0.373, respectively); therefore, it is an extremely useful marker for linkage analysis of FH in Caucasian populations.
Collapse
Affiliation(s)
- O Puig
- Instituto de Investigaciones Citológicas, Fundación Valenciana de Investigaciones Biomédicas, Spain
| | | | | | | | | | | |
Collapse
|
33
|
Chaves FJ, Puig O, García-Sogo M, Real J, Gil JV, Ascaso J, Carmena R, Armengod ME. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain. Clin Genet 1996; 50:28-35. [PMID: 8891383 DOI: 10.1111/j.1399-0004.1996.tb02342.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
We have performed restriction fragment length polymorphism (RFLP) analysis at the low density lipoprotein receptor (LDLR) locus in order to investigate the molecular genetics of familial hypercholesterolemia (FH) in Spain. Firstly, a sample of 50 unrelated patients with a clinical diagnosis of FH was screened for the presence of major rearrangements at this locus by Southern blot analysis of BglII digested genomic DNA. Four different mutations were detected, accounting for 8% of the mutant alleles in the Spanish FH sample. Then, we determined the relative allele frequency and estimated linkage disequilibrium between seven RFLPs of the LDLR gene in the remaining 46 FH patients and in 61 normolipidemic controls. HincII, AvaII, PvuII, MspI, and NcoI are the most polymorphic sites with individual PIC values higher than 0.28, whereas the TaqI and StuI sites display low levels of polymorphism. The usefulness of the seven RFLPs to confirm a clinical diagnosis of FH was investigated in 15 FH-families, consisting of 118 individuals, in whom the presence of Familial Defective Apolipoprotein B-100 (FDB) due to the apoB3500 mutation was excluded. Independent haplotypes were constructed for 71 chromosomes: 15 FH and 56 control haplotypes. A total of 14 different haplotypes was found. In 12 families, clinical diagnosis of FH was confirmed by cosegregation analysis, which makes these RFLPs useful for studying the inheritance of the LDLR gene in 80% of Spanish families with FH. Comparison of haplotypes found in the Spanish sample with those found in Swiss and Norwegians suggests heterogeneity of haplotypes among European populations.
Collapse
Affiliation(s)
- F J Chaves
- Instituto de Investigaciones Citológicas, Fundación Valenciana de Investigaciones Biomédicas, Spain
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Puig O, Real J, Chaves J, Garcia-Sogo M, Ascaso J, Carmena R. Seven DNA polymorphisms in the LDL receptor gene: Application to family studie in Spain. Atherosclerosis 1995. [DOI: 10.1016/0021-9150(95)96570-i] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Chaves F, Puig O, Real J, Garcia´-Sogo M, Gil J, Ascaso J, Armengod M, Carmena R. LDL receptor gene polymorphism in the diagnosis of familial hypercholesterolemia (FH). Atherosclerosis 1994. [DOI: 10.1016/0021-9150(94)93832-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
36
|
Tent J, Vidal M, Llauradó M, Rauret G, Real J, Mischler P. Sequential extraction as a tool to study the foliar uptake of radionuclides. J Radioanal Nucl Chem 1993. [DOI: 10.1007/bf02043040] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
|
38
|
Morillas C, Merchante A, Real J, Ascaso JF. [Hypoglycemic coma and advanced grade atrioventricular block with episodes of torsades de pointes]. Med Clin (Barc) 1993; 100:515. [PMID: 8479238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
|
39
|
Bayón J, Esteban P, Real J, Claver C, Polo A, Ruiz A, Castillón S. Catalytic hydroformylation of alkenes with cationic dinuclear rhodium(I) complexes, and the effect of the couter ions. J Organomet Chem 1991. [DOI: 10.1016/0022-328x(91)86488-c] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Bayón J, Net G, Real J, Rasmussen P. Synthesis and reactivity of rhodium(I) and iridium(I) complexes of the dianions of 2,3-pyrazinedicarboxylic and 2,5-pyrazinedicarboxylic acid. J Organomet Chem 1990. [DOI: 10.1016/0022-328x(90)85012-n] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
41
|
Polo A, Real J, Claver C, Castillón S, Bayón JC. Low-pressure selective hydroformylation of 2,3- and 2,5-dihydrofuran with a rhodium catalyst. Unexpected influence of the auxiliary ligand tris(o-t-butylphenyl) phosphite. ACTA ACUST UNITED AC 1990. [DOI: 10.1039/c39900000600] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
42
|
Bayón JC, Real J, Claver C, Polo A, Ruiz A. Selective hydroformylation with a recoverable dirhodium µ-thiolato complex. ACTA ACUST UNITED AC 1989. [DOI: 10.1039/c39890001056] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|